Treatment of Severe Asthma: Case Report of Fast Action of Mepolizumab in a Patient with Recent SARS-CoV-2 Infection
Asthma is one of the most common chronic inflammatory diseases of childhood with a heterogeneous impact on health and quality of life. Mepolizumab is an antagonist of interleukin-5, indicated as an adjunct therapy for severe refractory eosinophilic asthma in adolescents and children aged >6 years ol...
Gardado en:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI AG
2024-08-01
|
| Series: | Life |
| Assuntos: | |
| Acceso en liña: | https://www.mdpi.com/2075-1729/14/9/1063 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|